Atorvastatin increases ciclosporin exposure in liver transplant recipients

被引:0
|
作者
机构
关键词
Public Health; Cholesterol; Clinical Significance; Total Cholesterol; Cyclosporine;
D O I
10.2165/00128415-200409880-00003
中图分类号
学科分类号
摘要
引用
收藏
页码:3 / 3
相关论文
共 50 条
  • [1] Explaining variability in ciclosporin exposure in adult kidney transplant recipients
    Press, Rogier R.
    Ploeger, Bart A.
    den Hartigh, Jan
    van der Straaten, T.
    van Pelt, Hans
    Danhof, Meindert
    de Fijter, Hans
    Guchelaar, Henk-Jan
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 66 (06) : 579 - 590
  • [2] Explaining variability in ciclosporin exposure in adult kidney transplant recipients
    Rogier R. Press
    Bart A. Ploeger
    Jan den Hartigh
    T. van der Straaten
    Hans van Pelt
    Meindert Danhof
    Hans de Fijter
    Henk-Jan Guchelaar
    [J]. European Journal of Clinical Pharmacology, 2010, 66 : 579 - 590
  • [3] Effect of atorvastatin on cyclosporine pharmacokinetics in liver transplant recipients
    Taylor, PJ
    Kubler, PA
    Lynch, SV
    Allen, J
    Butler, M
    Pillans, PI
    [J]. ANNALS OF PHARMACOTHERAPY, 2004, 38 (02) : 205 - 208
  • [4] Ciclosporin versus tacrolimus for HCV transplant recipients
    Marina Berenguer
    [J]. Nature Reviews Gastroenterology & Hepatology, 2011, 8 : 422 - 424
  • [5] IMMUNOSUPPRESSION WITH SIROLIMUS INCREASES CARDIOVASCULAR RISK IN LIVER TRANSPLANT RECIPIENTS
    Doycheva, I. B.
    Couto, C. A.
    Gelape, C. L.
    Kish, J. K.
    Martin, P.
    Levy, C.
    [J]. JOURNAL OF HEPATOLOGY, 2012, 56 : S82 - S82
  • [6] The influence of atorvastatin on cyclosporin method for the measurement of cyclosporin pharmacokinetics in stable liver transplant recipients
    Taylor, PJ
    Lynch, SV
    Kubler, P
    Allen, J
    Butler, M
    Pillans, PI
    [J]. THERAPEUTIC DRUG MONITORING, 2003, 25 (04) : 506 - 506
  • [7] Safety and efficacy of atorvastatin in heart transplant recipients
    Patel, DN
    Pagani, FD
    Koelling, TM
    Dyke, DB
    Baliga, RR
    Cody, RJ
    Lake, KD
    Aaronson, KD
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2002, 21 (02): : 204 - 210
  • [8] Mycophenolic Acid Exposure after Administration of Mycophenolate Mofetil in the Presence and Absence of Ciclosporin in Renal Transplant Recipients
    Dirk R. Kuypers
    Henrik Ekberg
    Josep Grinyó
    Björn Nashan
    Flavio Vincenti
    Paul Snell
    Richard D. Mamelok
    Rene M. Bouw
    [J]. Clinical Pharmacokinetics, 2009, 48 : 329 - 341
  • [9] Mycophenolic Acid Exposure after Administration of Mycophenolate Mofetil in the Presence and Absence of Ciclosporin in Renal Transplant Recipients
    Kuypers, Dirk R.
    Ekberg, Henrik
    Grinyo, Josep
    Nashan, Bjoern
    Vincenti, Flavio
    Snell, Paul
    Mamelok, Richard D.
    Bouw, Rene M.
    [J]. CLINICAL PHARMACOKINETICS, 2009, 48 (05) : 329 - 341
  • [10] Blood and Plasma Pharmacokinetics of Ciclosporin in Diabetic Kidney Transplant Recipients
    Mendonza, Anisha E.
    Gohh, Reginald Y.
    Akhlaghi, Fatemeh
    [J]. CLINICAL PHARMACOKINETICS, 2008, 47 (11) : 733 - 742